Chad Bradford

448 total citations
15 papers, 241 citations indexed

About

Chad Bradford is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Chad Bradford has authored 15 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Chad Bradford's work include Computational Drug Discovery Methods (3 papers), Biochemical and Molecular Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Chad Bradford is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Biochemical and Molecular Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Chad Bradford collaborates with scholars based in United States, Germany and United Kingdom. Chad Bradford's co-authors include L.C. Altman, Roy C. Page, Kerry L. Tucker, Marc A. Willaredt, Igor Kitanović, Karin Gorgas, Joachim P. Spatz, Kerstin Hasenpusch‐Theil, Thomas Theil and Stefan Wölfl and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Chad Bradford

13 papers receiving 231 citations

Peers

Chad Bradford

GENET

PERIO

PPCH

Virginie G. Peter Switzerland

Yuan Jin China

Alisson C. Cardoso Brazil

Jessica Douglas United States

Daniel J. Adams United States

Jeffrey Dunmire United States

Emilie Ait‐Yahya France

Soma Ghosh United States

Mohammed E. El‐Asrag United Kingdom

Mahmoud Taleb Al‐Ali United Arab Emirates

Virginie G. Peter Switzerland

Chad Bradford

198 ×1.5

121 ×1.3

GENET

4 ×0.1

PERIO

41 ×1.1

10 ×0.4

PPCH

Citations per year, relative to Chad Bradford Chad Bradford (= 1×) peers Virginie G. Peter

Countries citing papers authored by Chad Bradford

Since Specialization

Citations

This map shows the geographic impact of Chad Bradford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Bradford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Bradford more than expected).

Fields of papers citing papers by Chad Bradford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad Bradford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Bradford. The network helps show where Chad Bradford may publish in the future.

Co-authorship network of co-authors of Chad Bradford

This figure shows the co-authorship network connecting the top 25 collaborators of Chad Bradford. A scholar is included among the top collaborators of Chad Bradford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad Bradford. Chad Bradford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bradford, Chad, Marija Mentinova, Daniel Chelsky, et al.. (2017). Analytical validation of protein biomarkers for risk of spontaneous preterm birth. PubMed. 3. 25–38. 11 indexed citations

Boggess, Kim, George R. Saade, Scott Sullivan, et al.. (2015). 193: Verification of a proteomic serum-based classifier to predict spontaneous preterm birth in asymptomatic patients. American Journal of Obstetrics and Gynecology. 214(1). S119–S119.

Kim, Seho, Rajendra Tangallapally, Daniel M. Parker, et al.. (2015). Discovery of an l-alanine ester prodrug of the Hsp90 inhibitor, MPC-3100. Bioorganic & Medicinal Chemistry Letters. 25(22). 5254–5257. 7 indexed citations

Gassman, Andrew, Le Hao, Leena T. Bhoite, et al.. (2013). Small Molecule Suppressors of Drosophila Kinesin Deficiency Rescue Motor Axon Development in a Zebrafish Model of Spinal Muscular Atrophy. PLoS ONE. 8(9). e74325–e74325. 8 indexed citations

Kumar, Dhiraj, Christophe Hoarau, Matthew G. Bursavich, et al.. (2012). Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(13). 4377–4385. 26 indexed citations

Baichwal, Vijay, J. Adam Willardsen, Jeffrey W. Lockman, et al.. (2011). Activity of the cancer metabolism inhibitor MPC-9528 in xenograft models: Comparison of different dosing schedules.. Journal of Clinical Oncology. 29(15_suppl). 10529–10529. 1 indexed citations

Carlson, Robert, Jeffrey W. Lockman, Chad Bradford, et al.. (2011). Abstract B137: Pharmacokinetics, antitumor activity, and therapeutic index of Nampt inhibitor MPC-8640 in mice.. Molecular Cancer Therapeutics. 10(11_Supplement). B137–B137. 1 indexed citations

Baichwal, Vijay, Ruth Gordillo, Tracey C. Fleischer, et al.. (2011). Abstract LB-393: The cancer metabolism inhibitor MPC-9528 induces tumor regression in xenograft models with multiple dosing schedules by causing rapid and sustained reduction in tumor NAD. Cancer Research. 71(8_Supplement). LB–393. 1 indexed citations

Papac, Damon I., J. S. Patton, Chad Bradford, et al.. (2011). Abstract 3233: Comparative in vitro and in vivo metabolism of MPC-3100, an oral HSP90 inhibitor, in rat, dog, monkey and human. Cancer Research. 71(8_Supplement). 3233–3233.

10.

Papac, Damon I., J. S. Patton, Chad Bradford, et al.. (2011). Abstract 3237: Evaluation of the pharmacokinetics and efficacy of a novel pro-drug of the HSP90 inhibitor, MPC-3100, designed with improved solubility. Cancer Research. 71(8_Supplement). 3237–3237. 1 indexed citations

11.

Fleischer, Tracey C., Vijay Baichwal, Chad Bradford, et al.. (2010). Abstract LB-288: MPI-0486348: A novel inhibitor of nicotinamide phosphoribosyltransferase (Nampt) induces tumor regression in a preclinical model. Cancer Research. 70(8_Supplement). LB–288. 2 indexed citations

12.

Willaredt, Marc A., Kerstin Hasenpusch‐Theil, Humphrey Gardner, et al.. (2008). A Crucial Role for Primary Cilia in Cortical Morphogenesis. Journal of Neuroscience. 28(48). 12887–12900. 112 indexed citations

13.

Zavitz, Kenton H., et al.. (2006). P2–411: MPC–7869 (R–flurbiprofen), a selective Ab42–lowering agent, displays no significant CYP2C9 drug–drug interactions: A phase 1 study. Alzheimer s & Dementia. 2(3S_Part_12). 1 indexed citations

14.

Bradford, Chad, et al.. (2005). MPC-6827, a small molecule inhibitor of microtubule formation with high brain penetration: absorption, distribution, metabolism, excretion, and clinical considerations. Cancer Research. 65. 804–804. 5 indexed citations

15.

Altman, L.C., et al.. (1985). Abnormalities of leukocyte chemotaxis in patients with various forms of periodontitis. Journal of Periodontal Research. 20(6). 553–563. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact